Biocon Limited has announced the approval of a Qualified Institutions Placement (QIP) of its equity shares, each with a face value of ₹5. The decision was made by the Fund Raising Committee during a meeting held on January 14, 2026. The Placement Document dated January 14, 2026, has been adopted in connection with this issue, marking a significant step for the company’s capital raising activities. The meeting commenced at 10:12 p.m. and concluded at 10:20 p.m.
Qualified Institutions Placement Approved
Biocon Limited has officially approved a Qualified Institutions Placement (QIP) of its equity shares. Each share has a face value of ₹5. This decision was finalized during a meeting of the company’s Fund Raising Committee held on January 14, 2026. The QIP is being executed under Chapter VI of specified regulations, related to the issue of capital and disclosure requirements.
Details of the Meeting
The Fund Raising Committee’s meeting, which led to this approval, took place on January 14, 2026. The meeting commenced at 10:12 p.m. and was concluded shortly after at 10:20 p.m., during which the committee approved and adopted the Placement Document dated January 14, 2026.
Placement Document Adopted
The company has adopted the Placement Document dated January 14, 2026, formalizing its plans for the issue. This document outlines the terms and conditions of the QIP. Biocon considers this a significant step for the company.
Source: BSE
